A brief history of placebos and clinical trials in psychiatry

Canadian Journal of Psychiatry

Volumn 56, Issue 4, 2011, Pages 193-197

  Shorter, Edward ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Controlled trial; Placebo treatment; Randomized controlled trial

Indexed keywords

ADENOSINE PHOSPHATE; AMINOPHYLLINE; AMPHETAMINE; CHLORAL HYDRATE; EPHEDRINE; LITHIUM; LYSERGIDE; MEPHENESIN; METHYLPENTYNOL; PENTOBARBITAL; PLACEBO;

CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DEPRESSION; DRUG EFFECT; DRUG EFFICACY; HISTORY; HUMAN; INFECTION; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL PRACTICE; MELANCHOLIA; NARCOLEPSY; PAIN; PLACEBO EFFECT; PRACTICE GUIDELINE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOPHRENIA; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 79957602413     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371105600402     Document Type: Review

References (24)

1. Nichols JTG. The misuses of drugs in modern practice. Massachusetts Medical Society, Medical Communications. 1893;16:3-46.
2. Kaptchuk TJ. Intentional ignorance: a history of blind assessment and placebo controls in medicine. Bull Hist Med. 1998;72:389-433. (Pubitemid 128461770)
3. Swartz CM, Shorter E. Psychotic depression. New York (NY): Cambridge University Press; 2007.
4. Kopeloff N, Cheney CO. Studies in focal infection: its presence and elimination in the functional psychoses. Am J Psychiatry. 1922;2:139-156.
5. Prinzmetal M, Bloomberg W. The use of Benzedrine for the treatment of narcolepsy. JAMA. 1935;105:2051-2054.
6. Gold H, Kwit NT, Otto H. The xanthines (theobromine and aminophylline) in the treatment of cardiac pain. JAMA. 1937;108:2173-2179.
7. Dub LA, Lurie LA. Use of Benzedrine in the depressed phase of the psychotic state. Ohio State Med J. 1939;35:39-45. The paper was first presented at a conference in 1938.
8. Wolff HG, Dubois EF, el. The use of placebos in therapy. N Y State J Med. 1946;46:1718-1727. Discussion.
9. Fisher RA. Statistical methods for research workers. Edinburgh (GB): Oliver and Boyd; 1925.
10. Fisher RA. The design of experiments. Edinburgh (GB): Oliver and Boyd; 1935.
11. Daniels M, Hall AB. Chemotherapy of pulmonary tuberculosis in young adults: an analysis of the combined results of three Medical Research Council trials. Br Med J. 1952;1:1162-1168.
12. Schou M. Lithium. In: Healy D, editor. The psychopharmacologists. Vol 2. London (GB): Chapman and Hall; 1998. p 259-284.
13. Schou M, Juel-Nielsen N, Strömgren E, et al. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954;17:250-260.
14. Lasagna L. A comparison of hypnotic agents. J Pharmacol Exp Ther. 1954;111:9-20.
15. Clancy J, Hoffer A, Lucy J, et al. Design and planning in psychiatric research as illustrated by the Weyburn chronic nucleotide project. Bull Menninger Clin. 1954;18:147-153.
16. Hampson JL, Rosenthal D, Frank JD. A comparative study of the effect of mephenesin and placebo on the symptomatology of a mixed group of psychiatric outpatients. Bull Johns Hopkins Hosp. 1954;95(4):170-177.
17. Davies DL, Shepherd M. Reserpine in the treatment of anxious and depressed patients. Lancet. 1955;2:117-120.
18. Rees WL, Lambert C. The value and limitations of chlorpromatine in the treatment of anxiety states. J Mental Sci. 1955;101:834-840.
19. Brody H. The lie that heals: the ethics of giving placebos. Ann Intern Med. 1982;97(1):112-118. (Pubitemid 12091291)
20. Shorter E. Before Prozac: the troubled history of mood disorders in psychiatry. New York (NY): Oxford University Press; 2009.
21. Kirsch I, Moore TJ, Scoboria A, et al. The emperor's new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration [Internet]. Prev Treat. 2002;5(Article 23), posted 2002 Jul 15 [date cited unknown]. Available from: http://www.journals.apa.org/prevention/ volume5/pre0050023a.html.
22. Lasagna L. Back to the future: evaluation and drug development 1948-1998. In: Healy D, editor. The psychopharmacologists. Vol 2. London (GB): Chapman and Hall; 1998. p 135-165.
23. Lasagna L. Decision processes in establishing the efficacy and safety of psychotropic agents. In: Prien RF, Robinson DS, editors. Clinical evaluation of psychotropic drugs: principles and guidelines. New York (NY): Raven Press; 1994. p 13-28.
24. Healy D. Trussed in evidence? Ambiguities at the interface between clinical evidence and clinical practice. Transcult Psychiatry. 2009;46:16-37.